Identification of autoantibody-negative autoimmune type 2 diabetic patients.
about
Hyaluronan: A Mediator of Islet Dysfunction and Destruction in Diabetes?Islet inflammation: a unifying target for diabetes treatment?The outliers become a stampede as immunometabolism reaches a tipping pointUse of a High-Density Protein Microarray to Identify Autoantibodies in Subjects with Type 2 Diabetes Mellitus and an HLA Background Associated with Reduced Insulin SecretionPrevalence of Positive Diabetes-Associated Autoantibodies among Type 2 Diabetes and Related Metabolic and Inflammatory Differences in a Sample of the Bulgarian PopulationIslet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetesImpact of islet autoimmunity on the progressive β-cell functional decline in type 2 diabetes.Neuronal T-cell autoreactivity is amplified in overweight children with new-onset insulin-requiring diabetes.Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trialAdaptive Immunity and Antigen-Specific Activation in Obesity-Associated Insulin Resistance.Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes.Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes.Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes'Sensing' the link between type 1 and type 2 diabetes.Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation.The potential role of glutamate in the current diabetes epidemic.Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus.Islet autoimmunity in phenotypic type 2 diabetes patients.Targeting inflammation in the treatment of type 2 diabetes.Diabetes and beta cell function: from mechanisms to evaluation and clinical implications.Latent autoimmune diabetes of the adult: current knowledge and uncertaintyDiabetes at the crossroads: relevance of disease classification to pathophysiology and treatment.Should There be Concern About Autoimmune Diabetes in Adults? Current Evidence and Controversies.T-cell receptor repertoire variation may be associated with type 2 diabetes mellitus in humans.Attenuation of islet-specific T cell responses is associated with C-peptide improvement in autoimmune type 2 diabetes patients.Family history of Type 1 diabetes affects insulin secretion in patients with 'Type 2' diabetes.Adult-onset autoimmune diabetes: current knowledge and implications for management.Identification of Unique Antigenic Determinants in the Amino Terminus of IA-2 (ICA512) in Childhood and Adult Autoimmune Diabetes: New Biomarker Development.Latent Autoimmune Diabetes in Adults: Current Status and New Horizons.
P2860
Q26799151-78736014-BAF4-49DE-B6A8-3B628DD3833CQ26860847-502CDE3E-9B89-4DAE-B533-ED59E3A62EECQ27005951-386A9959-0F1C-40A6-AAA8-2507E9E616E9Q28551169-A13B97DE-571A-4864-A72F-F12F05FAA257Q33717570-5E7D7FF3-8E72-4FDE-86D9-20CA6917CDEBQ34194600-F08E9310-F547-435B-ACFD-B1FB668D0A4EQ34545320-A766B788-0C60-4F33-837F-1A49D4655F70Q34762316-A8E90A5E-9774-4450-9999-5359497E47E1Q34803585-73D6D368-5972-459F-9862-F17C0BA1679DQ35753282-710107A9-37A5-4B75-BF8B-8352F77AC36BQ36330292-393D44B7-1BDC-4039-A318-120D51B5F835Q37331220-257B95ED-4547-4F2E-948A-020DC0BF5FEEQ37664028-ECE1945E-D9B8-4F33-95FE-A1CB7C25181CQ37954238-B2F64386-C206-4EDA-B2CA-F4F8681E241AQ37963478-1D2D7FC0-CC73-4A2F-9186-28D2F67F9A0DQ37973276-14B7FC99-BAF2-4D8C-81C4-23A21C5B4EC5Q38044705-C13D71DC-6C05-461D-A2BE-526BC32F696CQ38134110-C3FDDFF0-3106-409F-B60C-27953838E86BQ38134116-5D80FF26-7FFD-4178-BDAC-07F677A485F1Q38165184-7079A8EE-187C-425E-A502-1D99A4ABE781Q38324198-895E3F85-4616-495D-9E0A-E72B52F10898Q38615808-DEE219CB-80E4-42CC-A011-6A801455DBCAQ38908327-C76EA05B-E537-429D-B7FB-F241B7DA8767Q38959927-D40F05E7-4CD2-4AE8-BA01-9BF1344A759FQ44108133-270C5C6A-1FA3-40E2-841C-65467960E2A7Q46463492-2DC1E56C-6698-48DD-9055-41B90B213955Q47694295-22B7D60B-F6E8-4D11-8879-D5E754D99008Q48265104-9DB3A888-DA40-4ED8-B31F-F7FCF371A3A3Q55397117-F118DEDD-8973-4DC4-B5C8-320D66E7CD03
P2860
Identification of autoantibody-negative autoimmune type 2 diabetic patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Identification of autoantibody-negative autoimmune type 2 diabetic patients.
@ast
Identification of autoantibody-negative autoimmune type 2 diabetic patients.
@en
Identification of autoantibody-negative autoimmune type 2 diabetic patients.
@nl
type
label
Identification of autoantibody-negative autoimmune type 2 diabetic patients.
@ast
Identification of autoantibody-negative autoimmune type 2 diabetic patients.
@en
Identification of autoantibody-negative autoimmune type 2 diabetic patients.
@nl
prefLabel
Identification of autoantibody-negative autoimmune type 2 diabetic patients.
@ast
Identification of autoantibody-negative autoimmune type 2 diabetic patients.
@en
Identification of autoantibody-negative autoimmune type 2 diabetic patients.
@nl
P2093
P2860
P356
P1433
P1476
Identification of autoantibody-negative autoimmune type 2 diabetic patients.
@en
P2093
Barbara M Brooks-Worrell
Jerry P Palmer
Jessica L Reichow
P2860
P304
P356
10.2337/DC10-0579
P407
P50
P577
2010-09-20T00:00:00Z